Targeting human microRNA genes using engineered Tal-effector nucleases (TALENs).

MicroRNAs (miRNAs) have quickly emerged as important regulators of mammalian physiology owing to their precise control over the expression of critical protein coding genes. Despite significant progress in our understanding of how miRNAs function in mice, there remains a fundamental need to be able t...

Full description

Bibliographic Details
Main Authors: Ruozhen Hu, Jared Wallace, Timothy J Dahlem, David Jonah Grunwald, Ryan M O'Connell
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3646762?pdf=render
id doaj-ae8eb97003e4482a9245af5ef24533e7
record_format Article
spelling doaj-ae8eb97003e4482a9245af5ef24533e72020-11-25T01:44:39ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0185e6307410.1371/journal.pone.0063074Targeting human microRNA genes using engineered Tal-effector nucleases (TALENs).Ruozhen HuJared WallaceTimothy J DahlemDavid Jonah GrunwaldRyan M O'ConnellMicroRNAs (miRNAs) have quickly emerged as important regulators of mammalian physiology owing to their precise control over the expression of critical protein coding genes. Despite significant progress in our understanding of how miRNAs function in mice, there remains a fundamental need to be able to target and edit miRNA genes in the human genome. Here, we report a novel approach to disrupting human miRNA genes ex vivo using engineered TAL-effector (TALE) proteins to function as nucleases (TALENs) that specifically target and disrupt human miRNA genes. We demonstrate that functional TALEN pairs can be designed to enable disruption of miRNA seed regions, or removal of entire hairpin sequences, and use this approach to successfully target several physiologically relevant human miRNAs including miR-155*, miR-155, miR-146a and miR-125b. This technology will allow for a substantially improved capacity to study the regulation and function of miRNAs in human cells, and could be developed into a strategic means by which miRNAs can be targeted therapeutically during human disease.http://europepmc.org/articles/PMC3646762?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Ruozhen Hu
Jared Wallace
Timothy J Dahlem
David Jonah Grunwald
Ryan M O'Connell
spellingShingle Ruozhen Hu
Jared Wallace
Timothy J Dahlem
David Jonah Grunwald
Ryan M O'Connell
Targeting human microRNA genes using engineered Tal-effector nucleases (TALENs).
PLoS ONE
author_facet Ruozhen Hu
Jared Wallace
Timothy J Dahlem
David Jonah Grunwald
Ryan M O'Connell
author_sort Ruozhen Hu
title Targeting human microRNA genes using engineered Tal-effector nucleases (TALENs).
title_short Targeting human microRNA genes using engineered Tal-effector nucleases (TALENs).
title_full Targeting human microRNA genes using engineered Tal-effector nucleases (TALENs).
title_fullStr Targeting human microRNA genes using engineered Tal-effector nucleases (TALENs).
title_full_unstemmed Targeting human microRNA genes using engineered Tal-effector nucleases (TALENs).
title_sort targeting human microrna genes using engineered tal-effector nucleases (talens).
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description MicroRNAs (miRNAs) have quickly emerged as important regulators of mammalian physiology owing to their precise control over the expression of critical protein coding genes. Despite significant progress in our understanding of how miRNAs function in mice, there remains a fundamental need to be able to target and edit miRNA genes in the human genome. Here, we report a novel approach to disrupting human miRNA genes ex vivo using engineered TAL-effector (TALE) proteins to function as nucleases (TALENs) that specifically target and disrupt human miRNA genes. We demonstrate that functional TALEN pairs can be designed to enable disruption of miRNA seed regions, or removal of entire hairpin sequences, and use this approach to successfully target several physiologically relevant human miRNAs including miR-155*, miR-155, miR-146a and miR-125b. This technology will allow for a substantially improved capacity to study the regulation and function of miRNAs in human cells, and could be developed into a strategic means by which miRNAs can be targeted therapeutically during human disease.
url http://europepmc.org/articles/PMC3646762?pdf=render
work_keys_str_mv AT ruozhenhu targetinghumanmicrornagenesusingengineeredtaleffectornucleasestalens
AT jaredwallace targetinghumanmicrornagenesusingengineeredtaleffectornucleasestalens
AT timothyjdahlem targetinghumanmicrornagenesusingengineeredtaleffectornucleasestalens
AT davidjonahgrunwald targetinghumanmicrornagenesusingengineeredtaleffectornucleasestalens
AT ryanmoconnell targetinghumanmicrornagenesusingengineeredtaleffectornucleasestalens
_version_ 1725027300519444480